Corporate Corruption News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

Sidney M. Wolfe, an American physician turned activist who relentlessly lobbied against drug companies and the US Food and Drug Administration, died on Monday in his Washington home. He was 86. Wolfe ... co-founded the Public Citizen's Health Research Group, which "promotes research-based, system-wide changes in health-care policy and drug safety," according to the group's website. He also served as the director and senior adviser of the non-profit, where he crusaded against FDA rulings on more than two dozen dangerous or ineffective drugs until they were yanked off the market. In an op-ed published in HuffPost in 2011, Wolfe ridiculed the FDA for being "cautious on food safety – reckless on prescription drug safety." The banned medicines include the diabetes drug phenformin, which was linked to hundreds of deaths and sold under the trade names DBI and Meltrol in the US for 20 years. Wolfe was also responsible for the banning of the anti-inflammatory Vioxx ... which he warned caused serious heart damage years before it was taken off the market – as well as the anti-diarrheal alosetron. His group also successfully petitioned federal regulators to include a warning on aspirin bottles about Reye's syndrome, a rare but potentially fatal condition that causes swelling in the liver and brain. In addition, Wolfe was a fierce foe of silicone gel-filled breast implants for breast augmentation and reconstruction surgeries, claiming in the 1980s that they cause cancer.

Note: Read the full remembrance of Dr. Sidney Wolfe's legacy. His leadership helped remove 28 dangerous medications off the market, and paved the way for "vital and path-breaking research and advocacy on doctor discipline, mental health, tobacco, pharmaceutical marketing, drug company payments to doctors, medical devices, health insurance and the imperative of Medicare for All, unnecessary Cesarean sections, unregulated supplements, medical resident work hours, and more." For more along these lines, see concise summaries of deeply revealing news articles on health and Big Pharma corruption from reliable major media sources.

The former opinion editor of the New York Times, James Bennet, took his former employer to task recently in a lengthy essay. The headline of the piece boldly asserted that the New York Times has "lost its way." Inasmuch as the newspaper represents professional expectations and standards for the entire journalism world, Bennet could be translated as saying the broader news industry has also lost its way. The Times is just the largest float at the front of a parade heading in the wrong direction. Public sentiment about the news industry as a whole is at dismal levels. Gallup polling shows Americans' confidence in the news media to report in a "full, fair and accurate way" is at historically low levels. Given this lack of trust, it only stands to reason that Americans are less likely to follow the news at all. There is no need to consume news from sources one can't trust. Journalists rank near the bottom of public ratings of professions in terms of ethics and honesty. Activism has replaced journalism's former mission to provide fact-based information on which citizens can manage their lives and hold the powerful accountable. Of course, opinion and analysis have always been a part of journalism. But there has long been a sense in the journalism profession that such activist content was to be confined to designated sections, and that the news was to be fact-driven and balanced. Fairness is a skill that journalists once prided themselves on achieving.

Note: For more along these lines, see concise summaries of revealing news articles on media corruption from reliable sources.

The U.S. was in a fit of Covid panic during Thanksgiving week two years ago. By month's end, Pfizer's stock-market value had surpassed $300 billion, up 50% from the start of the pandemic. Moderna's shares had soared by more than 1,000% over the same period. In 2022 Pfizer became the first pharmaceutical company to book more than $100 billion in annual sales owing to government purchases of its vaccines and antiviral pill. Fast-forward to today. The pandemic is over. Demand for Covid vaccines and treatments has plunged. Pfizer's total revenue has fallen more than 40% since last year. Earlier this month the company took a $5.5 billion write-off on its Covid products owing to "lower-than-expected demand." Only 14% of American adults have received the latest updated booster shots. The jabs' greatest benefit was in providing political leaders with the courage to lift destructive lockdowns and mask mandates. The vaccines were supposed to be a two-shot-and-done regimen, not blockbuster medicines that rung up tens of billions of dollars in sales every year with government support. Statins and diabetes medicines prevent heart attacks, but the government doesn't run ads urging Americans to use Lipitor or Ozempic. The government's vaccine boosterism ... has increased public cynicism toward pharmaceutical companies. Drug makers can dine out on any given medicine only for so long before needing to cook up another pharmaceutical bonanza.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and coronavirus vaccines from reliable major media sources.

National Institutes of Health scientists raked in more than $325 million in royalties from Chinese and Russian entities – as well as pharmaceutical companies – over more than a decade, according to a new report. Former NIH director Dr. Francis Collins and former National Institutes of Allergy and Infectious Diseases (NIAID) director Dr. Anthony Fauci were among the thousands of government whitecoats who took the cash between September 2009 and October 2020, the taxpayer watchdog OpenTheBooks.com revealed. Several of those royalties came from companies that in turn received federal contracts and grants, prompting concerns about conflicts of interest. Unredacted documents obtained by the group through the Freedom of Information Act (FOIA) show at least 34 Chinese companies are licensing NIH technologies initially funded by US taxpayers. Some of those licensing fees came from the Wuhan Institute of Biological Products Co. Ltd., a subsidiary of the Chinese government-owned pharmaceutical company Sinopharm, which produced a COVID-19 vaccine. In 2016, the biological products company moved its headquarters next to the Wuhan Institute of Virology, where risky "gain-of-function" research funded by the US government may have led to the outbreak of the pandemic. The late Dr. Robert Chanock, the former head of the NIAID's laboratory of infectious diseases, and Dr. Jeffrey Cohen, his successor, were just a few of the virologists on the take from the Wuhan-based company.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the scientific community from reliable major media sources.

By March 2017, the fight over the construction of the Dakota Access pipeline had been underway for months. Law enforcement was ... discussing plans with Energy Transfer, the parent company of the Dakota Access pipeline. Throughout much of the uprising against the pipeline, the National Sheriffs' Association talked routinely with TigerSwan, Energy Transfer's lead security firm on the project, working hand in hand to craft pro-pipeline messaging. Documents, released by the North Dakota Private Investigation and Security Board, reveal how TigerSwan and the sheriffs' group worked together to twist the story in the media so that it aligned with the oil company's interests, seeking to pollute the public's perception of the water protectors. The private security firm pushed for the purchase, by Energy Transfer, of hundreds of thousands of dollars worth of radios for the cops. TigerSwan also placed an order for a catalog of so-called less-lethal weapons for police use, including tear gas. Off the Record Strategies, the public relations firm working for the National Sheriffs' Association, coordinated with the opposition research firm Delve to track activists' social media pages, arrest records, and funding sources. The companies sought to paint the protesters as violent, professional, billionaire-funded, out-of-state agitators whose camps represented the true ecological disaster, as well as to identify movement infighting that might be exploited.

Note: Read how TigerSwan treated water protectors as terrorists. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the erosion of civil liberties from reliable major media sources.

Vinyl chloride entered the spotlight after the Feb. 3 Ohio train derailment. But the hazardous substance has been around for decades and is everywhere – from buildings and vehicle upholstery to children's toys and kitchen supplies – and factories have been emitting the EPA-designated toxic chemical into the air for years. The train that derailed had the manmade and volatile compound on board, prompting temporary evacuations. But the derailment isn't the first time vinyl chloride has alarmed experts. Experts say that the volatile compound, "used almost exclusively by the plastics industry," has "leached into groundwater from spills, landfills, and industrial sources," and that people who live around plastic manufacturing facilities "may be exposed to vinyl chloride by inhalation of contaminated air." According to the EPA's Toxics Release Inventory (TRI), which "tracks the management of certain toxic chemicals that may pose a threat to human health and the environment," there are 38 TRI facilities in 15 states – mostly around the Gulf of Mexico and the eastern U.S. – that use vinyl chloride, emitting about half a million pounds of the substance every year. The problem begins at vinyl chloride's origins. It's generated from ethane, which is obtained through fracking natural gas. The U.S. Energy Information Administration said ethane production hit a monthly record last year of more than 2.4 million barrels per day. The global PVC market is expected to become a $56.1 billion industry within the next 3 years. 

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.

Google and YouTube are pouring millions into over 100 fact-checking organizations as part of a new Global Fact Check Fund aimed at stomping out misinformation online. On Tuesday, Google and YouTube announced a $13.2 million grant to the International Fact-Checking Network (IFCN) at the left-leaning nonprofit Poynter Institute. The IFCN previously labeled YouTube as one of the "major conduits" of disinformation and misinformation across the world. In an open letter, the IFCN proposed a partnership with YouTube to curb the issue. The new Global Fact Check Fund is expected to support its network of 135 fact-checking organizations across 65 countries, covering 80 languages. It is the largest grant Google and YouTube have ever shelled out regarding fact-checks. "Helping people to identify misinformation is a global challenge. The Global Fact Check Fund will help fact-checkers to scale existing operations or launch new ones that elevate information, uplift credible sources and reduce the harm of mis- and disinformation around the globe," Google said in Tuesday's press release. Google also noted that fact-checking organizations can use their new funding in a variety of ways, including new technologies, the creation or expansion of their digital footprints, new verification tools, and deeper audience engagement through audio, video or podcast formats. Since 2018, the Google News Initiative has invested nearly $75 million to "strengthen media literacy" and "combat misinformation."

Note: Freedom of expression is being greatly limited with the excuse of battling misinformation, which is often valuable, easily verifiable information the elite don't want us to know. Read this informative article to see how what is labeled as fact is many times just opinion or questionable government policy. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and media manipulation from reliable sources.

An offshore company that is trusted by the major web browsers and other tech companies to vouch for the legitimacy of websites has connections to contractors for U.S. intelligence agencies and law enforcement, according to security researchers, documents and interviews. Google's Chrome, Apple's Safari, nonprofit Firefox and others allow the company, TrustCor Systems, to act as what's known as a root certificate authority, a powerful spot in the internet's infrastructure that guarantees websites are not fake, guiding users to them seamlessly. The company's Panamanian registration records show that it has the identical slate of officers, agents and partners as a spyware maker identified this year as an affiliate of Arizona-based Packet Forensics, which ... has sold communication interception services to U.S. government agencies for more than a decade. TrustCor's products include an email service that claims to be end-to-end encrypted, though experts consulted by The Washington Post said they found evidence to undermine that claim. A test version of the email service also included spyware developed by a Panamanian company related to Packet Forensics. A person familiar with Packet Forensics' work confirmed that it had used TrustCor's certificate process and its email service, MsgSafe, to intercept communications and help the U.S. government catch suspected terrorists. The physical address in Toronto given in [TrustCor's] auditor's report, 371 Front St. West, houses a UPS Store mail drop.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the disappearance of privacy from reliable major media sources.

Gargantuan profits continue to roll in at Europe's energy giants. London-based Shell reported adjusted earnings of $9.45 billion for the third quarter, its second-highest profit on record. On the same day, Paris-based TotalEnergies reported a profit of $9.9 billion. For both companies, the profits were more than double what they earned in the same period a year ago. Shell and Total, like other energy companies this year, are benefiting from high oil and natural gas prices partly stoked by the war in Ukraine, as Russia squeezes gas flows to Europe. For Shell, the profit was a step down from the record-breaking $11.5 billion it reported for the second quarter, when it received an average of just over $100 a barrel for oil, compared with $93 in the third quarter. Natural gas prices, however, increased in the third quarter. Shell is returning a large chunk of this bounty to shareholders. The company said that it planned to increase its dividend to shareholders for the fourth quarter by 15 percent, to about 29 cents a share. In what may provoke a political storm in Britain, Shell said it had not yet been obliged to pay the "windfall" tax on oil and gas profits enacted earlier this year by the British government. The tax allows companies to deduct capital expenditures.

Note: Once again mega-corporations rake in the cash and stick it to the consumers. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.

When Covid-19 struck ... four organizations took on roles often played by governments – but without the accountability of governments. While nations were still debating the seriousness of the pandemic, the groups identified potential vaccine makers and targeted investments in the development of tests, treatments and shots. And they used their clout with the World Health Organization to help create an ambitious worldwide distribution plan. The largest and most powerful was the Bill & Melinda Gates Foundation, one of the largest philanthropies in the world. Then there was Gavi, the global vaccine organization that Gates helped to found to inoculate people in low-income nations, and the Wellcome Trust, a British research foundation with a multibillion dollar endowment that had worked with the Gates Foundation in previous years. Finally, there was the Coalition for Epidemic Preparedness Innovations, or CEPI, the international vaccine research and development group that Gates and Wellcome both helped to create in 2017. The organizations spent at least $8.3 million lobbying the U.S. and E.U., according to an analysis of lobbying disclosures. Now, critics are raising significant questions about the equity and effectiveness of the group's response to the pandemic – and the serious limitations of outsourcing the pandemic response to unelected, privately-funded groups.

Note: For more along these lines, see concise summaries of deeply revealing news articles on COVID from reliable major media sources.

Amazon will block and flag employee posts on a planned internal messaging app that contain keywords pertaining to labor unions, according to internal company documents reviewed by The Intercept. An automatic word monitor would also block a variety of terms that could represent potential critiques of Amazon's working conditions, like "slave labor," "prison," and "plantation," as well as "restrooms" – presumably related to reports of Amazon employees relieving themselves in bottles to meet punishing quotas. In November 2021, Amazon convened a high-level meeting in which top executives discussed plans to create an internal social media program that would let employees recognize co-workers' performance with posts called "Shout-Outs." But company officials also warned of what they called "the dark side of social media" and decided to actively monitor posts in order to ensure a "positive community." At the meeting, [head of worldwide consumer business, Dave] Clark suggested that the program should resemble an online dating app like Bumble, which allows individuals to engage one on one. Following the meeting, an "auto bad word monitor" was devised, constituting a blacklist that would flag and automatically block employees from sending a message that contains any profane or inappropriate keywords. Even some phrases like "This is concerning" will be banned. Managers will have the authority to flag or suppress any Shout-Outs that they find inappropriate.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.

The popular, once bipartisan idea to hold down Medicare costs is now at the center of President Joe Biden's domestic agenda. Legislation backed by the administration calls for Medicare to mirror other government agencies, such as the Department of Veterans Affairs, in being able to negotiate for cheaper medicine through the Part D program. The idea could potentially save the government nearly $500 billion over a decade. The drug pricing proposal could also translate to lower prescription costs across the board. The drug industry, according to its top lobbyist, Stephen Ubl, has made defeating the provision its top priority. Inside the Beltway, the opposition is coming from familiar faces. Many leading Democratic lawmakers and staff have been hired by the drug industry to convince their former colleagues to abandon the drug pricing proposal. Pfizer alone has assembled a lobbying team that includes Dean Aguillen, a former adviser to House Speaker Nancy Pelosi, D-Calif.; Remy Brim, a former health policy adviser to Sen. Elizabeth Warren, D-Mass.; and over half a dozen aides to senior Senate Democrats. Ann Jablon, former chief of staff to Rep. Richard Neal, D-Mass. ... currently represents several drug companies as a lobbyist, including Amgen Inc., Astellas Pharma, and Bayer. Pharmaceutical Research and Manufacturers of America, the trade group that represents the largest drug companies in the world, has also gone on a hiring spree of Democratic lobbyists.

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and Big Pharma profiteering from reliable major media sources.

Johnson & Johnson must pay a $2.1 billion award to women who claimed its baby powder was contaminated with cancer-causing asbestos, after the U.S. Supreme Court left intact the largest verdict in the almost decadelong litigation over the iconic product. The top U.S. court without comment on Tuesday refused to consider J&J's objections to a St. Louis jury's 2018 finding that its talc-based powder helped cause ovarian cancer in 20 women. J&J prepared for the appeal's denial by announcing in February it was setting aside almost $4 billion to cover the St. Louis verdict. The company still faces more than 25,000 lawsuits blaming baby powder for causing cancers. J&J pulled the product off U.S. and Canadian shelves last year. Jurors in the St. Louis case awarded each woman $25 million in compensatory damages. The panel then added more than $4 billion in punitive damages, making the award the sixth-largest in U.S. legal history. The original verdict sparked a significant drop in J&J's shares. J&J has lost other cases at trial, with juries across the U.S. ordering it to pay hundreds of millions of dollars. Judges slashed some of those awards while others have been thrown out or are on appeal. J&J has won cases as well. Asbestos, which is often found where talc is mined, is a recognized carcinogen. The women also contended that J&J showed years of deceit about its product and disregard for the health of its customers and argued that warranted the punitive damage award.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.

The pharmaceutical industry is distributing talking points, organizing opposition, and even collecting congressional signatures in an attempt to reverse President Joe Biden's support for worldwide access to generic Covid-19 vaccines. The behind-the-scenes moves ... come as the U.S. last week announced that it would support the World Trade Organization proposal, led by India and South Africa, to temporarily waive enforcement of intellectual property and patent rights on coronavirus vaccines. Without a radical expansion in vaccine manufacturing capacity, many developing countries will not achieve mass vaccination rates until 2023 or 2024. The waiver request, which was unexpectedly endorsed by Biden's administration on May 5, is designed to provide legal immunity for drug firms to copy the formulas of existing vaccines to supply low-cost vaccines to low-income countries. On Wednesday, Jared Michaud, a lobbyist with the Pharmaceutical Research and Manufacturers of America, a trade group that represents Pfizer, Johnson & Johnson, AstraZeneca, and other major drug firms, sent an email laying out the industry's role in coaxing lawmakers to push back against a waiver. One of the documents laid out potential national security concerns and suggested that lawmakers should argue the waiver could empower Russia and China. PhRMA ... spent over $24 million on federal lobbying last year and is one of the biggest corporate players in election spending.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus vaccine from reliable major media sources.

A week ago, the Biden administration announced support for waiving intellectual property protection for Covid-19 vaccines. In response, Bio, a trade association representing biotechnology companies, issued a statement saying, "The United States has unfortunately chosen to set a dangerous precedent with these actions." Efforts to maintain intellectual property rights from life-saving drugs to vaccines have hindered the global response. The Biden administration surprised a lot of observers by coming out in favor of this ... temporary suspension of IP and patent enforcement on certain medications related to the Covid-19 pandemic. Right now, the way that wealthier countries – the U.S. and others – are confronting this crisis for the developing world is through voluntary agreements. There are really two ways to combat this crisis. There's a way to do it in a sense that maximizes profit for the healthcare companies, the pharmaceutical companies. And then there's the more collaborative, nonprofit approach. And early on, pharmaceutical companies were fighting this more collaborative approach. The pharmaceutical companies, in addition, have said they plan to increase prices once the pandemic quote-unquote ends. These companies are eagerly awaiting the opportunity to increase prices.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus vaccine from reliable major media sources.

Sperm counts have been dropping; infant boys are developing more genital abnormalities; more girls are experiencing early puberty; and adult women appear to be suffering declining egg quality and more miscarriages. It's not just humans. Scientists report genital anomalies in a range of species, including unusually small penises in alligators, otters and minks. In some areas, significant numbers of fish, frogs and turtles have exhibited both male and female organs. Experts say the problem is a class of chemicals called endocrine disruptors, which mimic the body's hormones and thus fool our cells. This is a particular problem for fetuses as they sexually differentiate early in pregnancy. Endocrine disruptors can wreak reproductive havoc. These endocrine disruptors are everywhere: plastics, shampoos, cosmetics, cushions, pesticides, canned foods and A.T.M. receipts. They often aren't on labels and can be difficult to avoid. Chemical companies ... lobby against even safety testing of endocrine disruptors, so that we have little idea if products we use each day are damaging our bodies or our children. Still, the Endocrine Society, the Pediatric Endocrine Society, the President's Cancer Panel and the World Health Organization have all warned about endocrine disruptors, and Europe and Canada have moved to regulate them. But in the United States, Congress and the Trump administration seemed to listen more to industry lobbyists than to independent scientists.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.

Big corporations accused of driving environmental and health inequalities in black and brown communities through toxic and climate-changing pollution are also funding powerful police groups in major US cities, according to a new investigation. Some of America’s largest oil and gas companies, private utilities, and financial institutions that bankroll fossil fuels also back police foundations – opaque private entities that raise money to pay for training, weapons, equipment, and surveillance technology for departments across the US. The investigation by the Public Accountability Initiative, a nonprofit corporate and government accountability research institute ... details how police foundations in cities such as Seattle, Chicago, Washington, New Orleans and Salt Lake City are partially funded by household names such as Chevron, Shell and Wells Fargo. Police foundations are industry groups that provide substantial funds to local departments, yet, as nonprofits, avoid much public scrutiny. The investigation details how firms linked to fossil fuels also sponsor events and galas that celebrate the police, while some have senior staff serving as directors of police foundations. The report portrays the fossil fuel industry as a common enemy in the struggle for racial and environmental justice. “Many powerful companies that drive environmental injustice are also backers of the same police departments that tyrannize the very communities these corporate actors pollute,” it states.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in policing and in the corporate world from reliable major media sources.

Apple contractors regularly hear confidential medical information, drug deals, and recordings of couples having sex, as part of their job providing quality control, or “grading”, the company’s Siri voice assistant. Although Apple does not explicitly disclose it in its consumer-facing privacy documentation, a small proportion of Siri recordings are passed on to contractors working for the company around the world. Apple says the data “is used to help Siri and dictation ... understand you better and recognise what you say”. But the company does not explicitly state that that work is undertaken by humans who listen to the pseudonymised recordings. A whistleblower working for the firm, who asked to remain anonymous due to fears over their job, expressed concerns about this lack of disclosure, particularly given the frequency with which accidental activations pick up extremely sensitive personal information. The whistleblower said: “There have been countless instances of recordings featuring private discussions. These recordings are accompanied by user data showing location, contact details, and app data.” Although Siri is included on most Apple devices, the contractor highlighted the Apple Watch and the company’s HomePod smart speaker as the most frequent sources of mistaken recordings. As well as the discomfort they felt listening to such private information, the contractor said they were motivated to go public about their job because of their fears that such information could be misused.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the disappearance of privacy from reliable major media sources.

U.S. Senator Bernie Sanders plans to send a letter to Catalyst Pharmaceuticals on Monday asking it to justify its decision to charge $375,000 annually for a medication that for years has been available to patients for free. The drug, Firdapse, is used to treat Lambert-Eaton Myasthenic Syndrome (LEMS), a rare neuromuscular disorder. The disorder affects about one in 100,000 people in the United States. The government is intensifying its scrutiny of the pharmaceutical industry and rising prescription drug prices. Both the Democratic-led U.S. House of Representatives and the Senate, controlled by Republicans, have begun holding hearings this year on the rising costs of medicines. In the letter dated Feb. 4, Sanders asked Catalyst to lay out the financial and non-financial factors that led the company to set the list price at $375,000, and say how many patients would suffer or die as a result of the price and how much it was paying to purchase or produce the drug. For years, patients have been able to get Firdapse for free ... through a U.S. Food and Drug Administration (FDA) program called "compassionate use." The program allows patients with rare diseases and conditions access to experimental drugs outside of a clinical trial when there is no viable alternative. Florida-based Catalyst received FDA approval of Firdapse in November, along with exclusive rights to market the medication for several years. In December, Catalyst announced it would price Firdapse at $375,000 a year.

Note: Read how a major drug price increase nearly bankrupted the city of Rockford, Illinois. For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

People who work at the U.S. Food and Drug Administration (FDA) as medical reviewers are responsible for parsing the risks and benefits of a particular drug before it gets the agency's approval. But a new report from two researchers at the Oregon Health and Science University, published in the journal The BMJ, suggests many of these medical reviewers go on to work for the drug companies they oversaw while working for the government. The study's authors ... looked at the FDA's list of haematology-oncology drug approvals from 2006 to 2010 and scanned all medical reviews from 2001 to 2010 in the agency's database, then looked up the subsequent jobs of the people who worked as medical reviewers for those drug approvals. The researchers found that among 55 people who worked as haematology-oncology medical reviewers from 2001 to 2010, 27 continued in their roles at the FDA, two people worked at the FDA but held other appointments, and 15 left the FDA to work with or consult for the biopharmaceutical industry. "If you know in the back of your mind that a major career opportunity after the FDA is going to work on the other side of the table, I worry it can make you less likely to put your foot down," says study author Dr. Vinay Prasad. "Regulators may be less willing to be very tough, and I worry that is happening." Prasad says he would like to see more transparency from the FDA on the number of people who go from the agency to the drug industry.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in Big Pharma from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.